Paediatric presentation of type 2 neurofibromatosis

被引:124
作者
Evans, DGR
Birch, JM
Ramsden, RT
机构
[1] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England
[2] Royal Manchester Childrens Hosp, CRC, Paediat & Familial Canc Res Grp, Manchester M27 4HA, Lancs, England
[3] Manchester Royal Infirm, Dept Otolaryngol, Manchester M13 9WL, Lancs, England
关键词
neurofibromatosis type 2; meningioma; schwannoma; facial paralysis;
D O I
10.1136/adc.81.6.496
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background-Neurofibromatosis type 2 (NF2) is a highly penetrant autosomal dominant condition predisposing affected individuals to schwannomas and meningiomas. The proportion of children presenting with meningioma or schwannoma who have NF2 is not well described, and neither is the mode of presentation in most children with the inherited disease. Aims-To determine the frequency of childhood meningioma and schwannoma cases caused by NF2 and the mode of presentation. Methods-The records of the Manchester Children's Tumour Registry from 1954 were searched for cases of meningioma and schwannoma. Paediatric presentation in a large UK series of NF2 was also studied. Results-18% (61/334) of patients with NF2 on the UK database presented in the paediatric age group (0-15 years), frequently with the symptoms of an isolated tumour. More than half had no family history to alert the clinician to their susceptibility. Three of 22 children presenting with a meningioma on the Manchester Children's Tumour Registry have gone on to develop classic features of NF2. Conclusions-Clinicians should suspect NF2 in children presenting with meningioma, schwannoma, and skin features, such as neurofibromas/schwannomas, but fewer than 6 cafe au lait patches, who thus fall short of a diagnosis of neurofibromatosis type 1.
引用
收藏
页码:496 / 499
页数:4
相关论文
共 24 条
[1]  
Cushing H, 1917, Tumors of the Nervus Acusticus and the Syndrome of the Cerebellopontile Angle
[2]   A GENETIC-STUDY OF TYPE-2 NEUROFIBROMATOSIS IN THE UNITED-KINGDOM .2. GUIDELINES FOR GENETIC-COUNSELING [J].
EVANS, DGR ;
HUSON, SM ;
DONNAI, D ;
NEARY, W ;
BLAIR, V ;
NEWTON, V ;
STRACHAN, T ;
HARRIS, R .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) :847-852
[3]   Uptake of genetic testing for cancer predisposition [J].
Evans, DGR ;
Maher, ER ;
Macleod, R ;
Davies, DR ;
Craufurd, D .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (09) :746-748
[4]   TYPE-2 NEUROFIBROMATOSIS - THE NEED FOR SUPRAREGIONAL CARE [J].
EVANS, DGR ;
RAMSDEN, R ;
HUSON, SM ;
HARRIS, R ;
LYE, R ;
KING, TT .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1993, 107 (05) :401-406
[5]   A GENETIC-STUDY OF TYPE-2 NEUROFIBROMATOSIS IN THE UNITED-KINGDOM .1. PREVALENCE, MUTATION-RATE, FITNESS, AND CONFIRMATION OF MATERNAL TRANSMISSION EFFECT ON SEVERITY [J].
EVANS, DGR ;
HUSON, SM ;
DONNAI, D ;
NEARY, W ;
BLAIR, V ;
TEARE, D ;
NEWTON, V ;
STRACHAN, T ;
RAMSDEN, R ;
HARRIS, R .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) :841-846
[6]   Somatic mosaicism: A common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis [J].
Evans, DGR ;
Wallace, AJ ;
Wu, CL ;
Trueman, L ;
Ramsden, RT ;
Strachan, T .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) :727-736
[7]   Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations [J].
Evans, DGR ;
Trueman, L ;
Wallace, A ;
Collins, S ;
Strachan, T .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (06) :450-455
[8]  
EVANS DGR, 1992, Q J MED, V84, P603
[9]   VONRECKLINGHAUSEN NEUROFIBROMATOSIS - A CLINICAL AND POPULATION STUDY IN SOUTHEAST WALES [J].
HUSON, SM ;
HARPER, PS ;
COMPSTON, DAS .
BRAIN, 1988, 111 :1355-1381
[10]   Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes [J].
Kluwe, L ;
Bayer, S ;
Baser, ME ;
Hazim, W ;
Haase, W ;
Funsterer, C ;
Mautner, VF .
HUMAN GENETICS, 1996, 98 (05) :534-538